Assessing behavioral syndromes in patients with brain tumors using the frontal systems behavior scale (FrSBe)

Neuro-oncology Practice
Sergio CabreraMaria Carmela Tartaglia

Abstract

Personality changes following brain tumors may be due to disruption of frontal-subcortical networks. The relation between personality changes and tumor parameters such as volumes of the surgical cavity, residual tumor, or nonspecific white matter abnormalities is unknown. In this study we examined the relation between these tumor parameters and abnormal behaviors typically associated with frontal lobe dysfunction. Thirty-one patients with intracranial tumors who completed the Frontal Systems Behavior Scale (FrSBe) during clinical neuropsychological assessment and had a solitary, well-delimited brain lesion on MRI within 3 months of that assessment were included. Tumor parameters were manually segmented using OsiriX. Nonparametric statistics were used to determine the relationship between tumor parameters and frontal behavioral dysfunction as measured by FrSBe scores. Patients reported significantly more behavior problems after tumor diagnosis. Tumor cavity volume was correlated with self-reported Executive Dysfunction (rho = 0.450, P = .047), and there was a trend in the relationship with self-reported Apathy (rho = 0.438, P = .053). Nonspecific white matter abnormality volume was also correlated with self-reported Apathy (rho ...Continue Reading

References

Apr 1, 1992·Annals of Neurology·L D RechtT W Smith
Jan 1, 1986·Annual Review of Neuroscience·G E AlexanderP L Strick
Aug 1, 1993·Archives of Neurology·J L Cummings
Dec 15, 1995·Annals of the New York Academy of Sciences·J L Cummings
Aug 1, 1996·Neurosurgery·J G OjemannD L Silbergeld
Jan 1, 1997·Journal of Psychopharmacology·D L Masterman, J L Cummings
May 23, 1998·Journal of Neurology, Neurosurgery, and Psychiatry·M L van VeelenC Vecht
Jul 2, 1998·Brain : a Journal of Neurology·M M Mesulam
Apr 6, 2000·Neurology·J D OlsonL M DeAngelis
Oct 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M KleinN K Aaronson
Apr 5, 2003·Assessment·Julie C StoutJane S Paulsen
Jun 18, 2003·Journal of Neurology, Neurosurgery, and Psychiatry·H DuffauR Van Effenterre
Jul 11, 2003·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·David G AndrewesLisa Bates
Feb 26, 2004·Lancet Neurology·Martin J B Taphoorn, Martin Klein
Mar 11, 2004·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Tom N Tombaugh
Nov 10, 2004·Journal of Digital Imaging·Antoine RossetOsman Ratib
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Mar 12, 2005·Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology·Paul Malloy, Janet Grace
Mar 19, 2005·Journal of Neurology, Neurosurgery, and Psychiatry·A R GiovagnoliA Boiardi
Oct 1, 2005·Brain : a Journal of Neurology·Howard J RosenBruce L Miller
Dec 3, 2005·The Lancet Oncology·Martin J B TaphoornUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Dec 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul D BrownJan C Buckner
Mar 30, 2007·Brain : a Journal of Neurology·Ingrid R OlsonYoussef Ezzyat
Mar 8, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Justin S SmithMitchel S Berger
Jul 1, 2007·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Paul MalloyLaura Frakey
Oct 13, 2009·NeuroImage·Mikail Rubinov, Olaf Sporns
Feb 18, 2010·Developmental Review : DR·John R BestLara L Jones
Oct 5, 2010·International Journal of Radiation Oncology, Biology, Physics·Jing LiMinesh P Mehta
Oct 17, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gregory CairncrossMinesh Mehta
Jun 27, 2013·Assessment·Janessa O CarvalhoJanet Grace
May 29, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·N GreggL Yágüez
Jul 6, 2014·European Journal of Cancer Care·M Pérez-CampdepadrósT Blasco-Blasco
Feb 18, 2015·Nature Reviews. Neurology·Niels D Prins, Philip Scheltens
Mar 12, 2015·Journal of Neurotrauma·Serguei V AstafievMaurizio Corbetta

❮ Previous
Next ❯

Citations

Jul 10, 2020·Journal of the International Neuropsychological Society : JINS·Rella J KautiainenTricia Z King

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Neuropsychiatric Disease and Treatment
Linda MahSheldon Benjamin
Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology
Nancy D Chiaravalloti, John DeLuca
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases
Alison B GrossmanRobert G Miller
© 2021 Meta ULC. All rights reserved